MedPath

INSIGHT THERAPEUTICS, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks

Phase 4
Active, not recruiting
Conditions
Influenza, Human
Influenza
Influenza -Like Illness
Interventions
First Posted Date
2021-08-19
Last Posted Date
2023-03-15
Lead Sponsor
Insight Therapeutics, LLC
Target Recruit Count
1000
Registration Number
NCT05012189
Locations
🇺🇸

Insight Therapeutics, LLC, Norfolk, Virginia, United States

Recombinant Influenza Vaccination in U.S. Nursing Homes

Phase 4
Active, not recruiting
Conditions
Influenza, Human
Influenza -Like Illness
Influenza
Interventions
Biological: Recombinant Influenza Vaccine
Biological: Standard Dose Quadrivalent Influenza Vaccine
First Posted Date
2019-05-28
Last Posted Date
2023-03-15
Lead Sponsor
Insight Therapeutics, LLC
Target Recruit Count
1989
Registration Number
NCT03965195
Locations
🇺🇸

Insight Therapeutics, LLC, Norfolk, Virginia, United States

Adjuvanted Influenza Vaccination Year 2 Follow-On Survey

Completed
Conditions
Influenza
Influenza-like Illness
Influenza, Human
Interventions
Biological: Influenza
First Posted Date
2018-07-26
Last Posted Date
2023-03-16
Lead Sponsor
Insight Therapeutics, LLC
Target Recruit Count
598
Registration Number
NCT03599739
Locations
🇺🇸

Insight Therapeutics, LLC, Norfolk, Virginia, United States

A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting

Not Applicable
Completed
Conditions
Urinary Incontinence
Interventions
Other: Care planning without using TENA Identifi sensor wear data
Other: Care planning using TENA Identifi sensor wear data
First Posted Date
2017-07-06
Last Posted Date
2019-07-26
Lead Sponsor
Insight Therapeutics, LLC
Target Recruit Count
49
Registration Number
NCT03209570
Locations
🇺🇸

Chesapeake Health & Rehabilitation Center, Chesapeake, Virginia, United States

🇺🇸

Norfolk Health & Rehabilitation Center, Norfolk, Virginia, United States

🇺🇸

Insight Therapeutics, LLC, Norfolk, Virginia, United States

and more 2 locations

Immunogenicity of Influenza Vaccine in Long Term Care

Not Applicable
Conditions
Influenza
Interventions
Procedure: Blood Draw
First Posted Date
2016-10-14
Last Posted Date
2021-03-09
Lead Sponsor
Insight Therapeutics, LLC
Target Recruit Count
200
Registration Number
NCT02933723
Locations
🇺🇸

Case Western Reserve University, Cleveland, Ohio, United States

Adjuvanted Influenza Vaccination in U.S. Nursing Homes

Phase 4
Completed
Conditions
Influenza-like Illness
Influenza
Interventions
Biological: adjuvanted trivalent influenza vaccine
Biological: trivalent influenza vaccine
First Posted Date
2016-08-29
Last Posted Date
2023-03-15
Lead Sponsor
Insight Therapeutics, LLC
Target Recruit Count
823
Registration Number
NCT02882100
Locations
🇺🇸

Insight Therapeutics, LLC, Norfolk, Virginia, United States

High-Dose Influenza Vaccine in Nursing Homes

Phase 4
Conditions
Influenza
Interventions
Biological: SD Vaccine
Biological: HD Vaccine
Biological: Free Vaccine
Biological: Usual Care
First Posted Date
2013-03-21
Last Posted Date
2018-07-16
Lead Sponsor
Insight Therapeutics, LLC
Target Recruit Count
823
Registration Number
NCT01815268
Locations
🇺🇸

Brown University, Providence, Rhode Island, United States

🇺🇸

Case Western Reserve University, Cleveland, Ohio, United States

🇺🇸

Insight Therapeutics, LLC, Norfolk, Virginia, United States

High Dose Influenza Vaccine in Nursing Home - Pilot Study

Phase 4
Completed
Conditions
Influenza
Interventions
Biological: HD Fluzone Vaccine
Biological: SD Fluzone Vaccine
First Posted Date
2012-11-02
Last Posted Date
2018-05-23
Lead Sponsor
Insight Therapeutics, LLC
Target Recruit Count
2957
Registration Number
NCT01720277
Locations
🇺🇸

Brown Univeristy, Providence, Rhode Island, United States

🇺🇸

Insight Therapeutics, Norfolk, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath